Provided by Tiger Fintech (Singapore) Pte. Ltd.

Alexander's

201.85
+3.001.51%
Post-market: 201.850.00000.00%19:56 EDT
Volume:9.77K
Turnover:1.96M
Market Cap:1.03B
PE:23.86
High:202.50
Open:199.53
Low:199.53
Close:198.85
Loading ...

ALX Oncology Strengthens Leadership with Key Appointments

TIPRANKS
·
22 Jan

Press Release: ALX Oncology Announces Further Additions to Leadership Team and Board of Directors, Appointing Harish Shantharam as Chief Financial Officer and Adding Barbara Klencke and Chris Takimoto to Board of Directors

Dow Jones
·
22 Jan

ALX Oncology to Host Virtual Company Event Highlighting Updated Data from ASPEN-06 Phase 2 Trial Presented at 2025 ASCO GI

GlobeNewswire
·
22 Jan

ALX Oncology Adopts 2025 Inducement Equity Plan

TIPRANKS
·
18 Jan

ALX Oncology to Present at the 43rd Annual J.P. Morgan Healthcare Conference

GlobeNewswire
·
07 Jan

Greenridge Exploration Expands with ALX Acquisition

TIPRANKS
·
31 Dec 2024

TPG in Advanced Talks to Acquire Crown Castle's Fiber Unit

Zacks
·
21 Dec 2024

ALX Oncology Shares Fall After Downgrade From Jefferies

MT Newswires Live
·
20 Dec 2024

Here's Why You Should Retain Ventas Stock in Your Portfolio Now

Zacks
·
20 Dec 2024

Jefferies Downgrades ALX Oncology to Hold From Buy, Cuts Price Target to $2 From $12

MT Newswires Live
·
19 Dec 2024

ALX Oncology to Present Updated Results from Phase 2 ASPEN-06 Clinical Trial of Evorpacept in Patients with HER2-Positive Gastric Cancer in Oral Presentation at 2025 ASCO Gastrointestinal Cancers Symposium

GlobeNewswire
·
18 Dec 2024

ALX Oncology Price Target Maintained With a $25.00/Share by HC Wainwright & Co.

Dow Jones
·
18 Dec 2024

ALX Oncology Holdings (ALXO) Gets a Hold from LifeSci Capital

TIPRANKS
·
18 Dec 2024

ALX Oncology to host virtual event to discuss Phase 1b/2 evorpacept data

TIPRANKS
·
12 Dec 2024

ALX Oncology to Host Virtual Company Event Highlighting New Clinical Data Presented at SABCS 2024

GlobeNewswire
·
12 Dec 2024

ALX Oncology Announces New Data Demonstrating Evorpacept in Combination with Zanidatamab Generates Promising Antitumor Activity in Advanced Breast Cancer

GlobeNewswire
·
10 Dec 2024

ALX Oncology to Participate in the Piper Sandler 36th Annual Healthcare Conference

GlobeNewswire
·
26 Nov 2024

ALX Oncology Holdings (ALXO) Loses -27.11% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Zacks
·
21 Nov 2024

ALX Oncology Strengthens Leadership with Key Appointment

TIPRANKS
·
14 Nov 2024

Press Release: ALX Oncology Appoints Alan Sandler, M.D., as Chief Medical Officer

Dow Jones
·
14 Nov 2024